Hotmail
FDA blocks imports of 30 generic drugs
Government closes U.S. borders to meds from two plants in India
 | Health care videos |
 Public option a barrier to reform? Nov. 25: Is a proposed government health insurance option getting in the way of landmark health care legislation? Sen. Thomas Carper, D-Del., and guest host Chuck Todd, discuss. |
 | INTERACTIVE |
 | Dose of reality Do health care reform headlines leave you saying “huh?” Visit msnbc.com's guide to health reform and send us claims you'd like fact-checked. |
WASHINGTON - The government is closing U.S. borders to more than 30 generic drugs — including popular antibiotics and cholesterol medicines — made by India's drug giant Ranbaxy Laboratories because of poor quality in two of its factories.
The Food and Drug Administration says consumers who already have the drugs shouldn't worry: Repeated testing hasn't found any contamination, and Ranbaxy can continue selling medicines made at any of its other factories.
The showdown instead is over what the FDA says is Ranbaxy's failure to correct significant manufacturing problems that could lead to subpotent drugs, allergic reactions or other problems.
The move also may affect a U.S. program sending AIDS drugs to Africa, as Ranbaxy is a leading supplier.
- Discuss Story On Newsvine
-
Rate Story:
View popularLowHigh - Instant Message
MORE FROM HEALTH CARE |
 Health care Section Front |
| Add Health care headlines to your news reader: |
Resource guide